Live Breaking News & Updates on Comirnaty

Stay informed with the latest breaking news from Comirnaty on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Comirnaty and stay connected to the pulse of your community

Pfizer confirms laying off 200 employees

In a statement sent early Friday morning, pharmaceutical giant, Pfizer confirmed they are laying off approximately 200 people from their Kalamazoo facility.

Pfizer , 200-laid-off-from-pfizer , Comirnaty , Covid , Covid-19 , Covid19 , Kalamazoo , Layoff , Paxlovid , Pifzer , Portage

Downturn in US demand leads to course correction for COVID-19 vaccines, therapy

The vagaries of the COVID-19 market and the uncertainties of pandemic fatigue are hitting some biopharma companies in the pocketbook, at least for now. Due to lower-than-expected revenues from its COVID-19 Comirnaty vaccine and antiviral Paxlovid (nirmatrelvir/ritonavir), Pfizer Inc. reduced its 2023 revenue guidance by $9 billion after hours Oct. 13, saying it now anticipates full-year 2023 revenues to range from $58 billion to $61 billion – down from its previous guidance range of $67 billion to $70 billion.

Pfizer-inc , Covid-19 , Pfizer-inc- , Paxlovid , Comirnaty , Moderna-inc- , Spikevax , Biontech-se ,

Is Pfizer in danger of fallout after the COVID-19 pandemic?

Despite the pharmaceutical company's COVID-19 vaccine which saved millions of lives, the company could now be in danger of collapse in subsequent years.

United-kingdom , United-states , Russia , Ukraine , North-carolina , Poland , Rocky-mount , American , Russian , Adam-niedzielski , Poland-health , Pfizer

BioNTech COVID vaccine faces 1st German lawsuit over side effects

German vaccine-maker BioNTech faced Monday its first legal claim in its home country over adverse effects allegedly suffered by some users of its COVID-19...

Germany , Hamburg , France , United-kingdom , Munich , Bayern , German , Britain , Thomas-ulbrich , Anja-dornhoff , Joachim-caesar-preller , Paul-ehrlich-institute

UK health regulator authorizes Moderna COVID vaccine for infants as young as 6 months

Spikevax becomes 2nd COVID-19 vaccine to be authorized for children aged 6 months to 5 years, says regulator - Anadolu Ajansı

United-kingdom , Anadolu , Turkey-general- , Turkey , London , City-of , Britain , Regulatory-agency , Anadolu-agency , World-health-organization , Broadcasting-system

Welcome To IANS Live - LatestNews - Pfizer sees big reversal after reporting record high revenues, earnings in 2022

Pfizer on Tuesday reported $100.3 billion of revenues and $6.58 of adjusted diluted earnings per share (EPS) in 2022, both of which hit record highs.Pfiz

New-york , United-states , Albert-bourla , Pfizer , Pfizer-inc , Xinhua , Chief-executive-officer , Revenues , Billion , Diluted , Adjusted , Comirnaty

Welcome To IANS Live - INTERNATIONAL - Pfizer sees big reversal after reporting record high revenues, earnings in 2022

Pfizer on Tuesday reported $100.3 billion of revenues and $6.58 of adjusted diluted earnings per share (EPS) in 2022, both of which hit record highs.Pfiz

New-york , United-states , Albert-bourla , Pfizer , Pfizer-inc , Xinhua , Chief-executive-officer , Revenues , Billion , Diluted , Adjusted , Comirnaty

Pfizer Share Prices Fall 3% After Drugmaker Claims Low Earnings Forecast in 2023

Pfizer surprised Wall Street with a prediction for a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. Pfizer Share Prices Fall 3% After Drugmaker Claims Low Earnings Forecast in 2023.

New-york , United-states , Pfizer , Pfizer-inc , Wall-street , Children-under , Arthritis-drug-can-cut-death-risk , New-york-based-pfizer , Comirnaty , Covid-19-vaccine , Drugmaker